Amyloidosis trials in Türkiye

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Ankara, Antalya, Istanbul

  Age

  18 years to 85 years

  People

  1,750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00
• Phase 3Taking people
  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Where

  Istanbul, Izmir

  Age

  18 years to 85 years

  People

  125 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07223203 · EU 2025-522544-40-00
• Phase 3Not yet taking people in Türkiye
  An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy

  Where

  Dinar, Eskişehir, Istanbul, Mersin

  People

  1,180 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT07789483 · EU 2026-526755-57-00